| |
CELATOR PHARMACEUTICALS ANNOUNCES ENROLLMENT OF FIRST PATIENT IN PHASE 2 STUDY WITH CPX-351 |
|
| 11/18/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
INTERIM ANALYSIS OF TOP-LINE DATA FROM PHASE II/III STUDY SHOWS FAVORABLE EFFICACY & SAFETY FOR CORTHERA’S RELAXIN IN ACUTE HEART FAILURE |
|
| 11/10/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
BIPAR SCIENCES' LEAD COMPOUND SELECTED AS TOP 10 ONCOLOGY DRUG CANDIDATE |
|
| 10/28/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
MARINUS COMPLETES TWO PHASE 2 MILESTONES FOR GANAXOLONE IN EPILEPSY |
|
| 10/7/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
ALIMERA REPORTS RESULTS FROM THE SIX-MONTH INTERIM READOUT OF THE HUMAN PK ILUVIEN™ STUDY |
|
| 10/1/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
OCEANA THERAPEUTICS COMMENCES OPERATIONS AFTER COMPLETING SERIES A FINANCING ROUND |
|
| 9/29/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
GI DYNAMICS ANNOUNCES SHORT-TERM WEIGHT LOSS RESULTS IN MORBIDLY OBESE PATIENTS |
|
| 9/26/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
GI DYNAMICS ANNOUNCES DATA THAT SHOWS ENDOBARRIER REDUCES HBA1C IN PATIENTS WITH TYPE 2 DIABETES |
|
| 9/16/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
FIVEPRIME INITIATES PHASE I OF FP-1039 IN PATIENTS WITH ADVANCED CANCERS |
|
| 9/8/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
COLUCID PRESENTS PHASE II RESULTS OF COL-144 AT THE EUROPEAN HEADACHE AND MIGRAINE TRUST INTERNATIONAL CONGRESS 2008 |
|
| 9/5/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
CELATOR RECEIVES ORPHAN DRUG DESIGNATION FOR CPX-351 |
|
| 9/4/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
REGADO BIOSCIENCES REPORTS CLINICAL RESULTS FOR REG1 ANTICOAGULATION SYSTEM AT EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2008 |
|
| 9/4/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
ZOGENIX CLOSES $18 MILLION FINANCING WITH OXFORD FINANCE CORPORATION AND CIT HEALTHCARE LLC |
|
| 8/5/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
MARINUS APPOINTS JOHN KRAYACICH AS PRESIDENT AND CEO |
|
| 8/5/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
DAVID J. MAZZO, PH.D., JOINS REGADO BIOSCIENCES AS PRESIDENT AND CEO |
|
| 8/4/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
CELATOR RAISES SERIES C FINANCING IN EXCESS OF $22.5 MILLION |
|
| 7/28/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
ALTEA PARTNERS TRANSDERMAL PRODUCT WITH HOSPIRA |
|
| 7/2/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
COLUCID CLOSES $25 MILLION SERIES B FINANCING |
|
| 7/1/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
ZOGENIX TO PRESENT DOSEPRO RESULTS AT ANNUAL AMERICAN HEADACHE SOCIETY MEETING |
|
| 6/28/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
VANDA ANNOUNCES POSITIVE TOP-LINE PHASE III DATA OF TASIMELTON IN ADULTS WITH CHRONIC INSOMNIA |
|
| 6/26/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
ALIMERA REPORTS RESULTS FROM THE THREE-MONTH INTERIM READOUT OF THE HUMAN PK MEDIDUR FA STUDY |
|
| 6/26/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
CELL BIOSCIENCES ANNOUNCES NEW LEADERSHIP |
|
| 6/24/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
MERITAGE PHARMA CLOSES $22.5 MILLION SERIES A FINANCING |
|
| 6/16/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
MERITAGE ACQUIRES PEDIATRIC GASTROINTESTINAL PROGRAM FROM VERUS PHARMACEUTICALS |
|
| 6/16/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
GIDYNAMICS PRESENTS INITIAL RESULTS AT ADA |
|
| 6/13/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
GENVAULT CORPORATION RAISES $13 MILLION OF VENTURE FINANCING |
|
| 6/9/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
OREXIGEN: CONTRAVE MAY REVERSE THE INCIDENCE OF METABOLIC SYNDROME |
|
| 6/7/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
VANDA AND LABCORP COLLABORATE TO OFFER GENETIC TESTS |
|
| 6/5/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
CELATOR REPORTS POSITIVE PHASE 2 DATA FOR CPX-1 IN COLORECTAL CANCER |
|
| 6/3/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
VENTIRX APPOINTS DR. ELLIOT GROSSBARD TO BOARD OF DIRECTORS |
|
| 5/20/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
FIVEPRIME AND PFIZER ENTER ONCOLOGY AND DIABETES COLLABORATION |
|
| 5/20/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
NOVALAR RECEIVES FDA APPROVAL FOR ORAVERSE |
|
| 5/12/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
CELATOR PHARMACEUTICALS APPOINTS SCOTT JACKSON AS CEO |
|
| 5/9/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
FIVE PRIME REPORTS DISCOVERY OF IL-34, A NOVEL CYTOKINE |
|
| 5/8/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
ESPERION THERAPEUTICS COMPLETES $22.75M SERIES A FINANCING |
|
| 5/1/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
NUON THERAPEUTICS INC. COMPLETES $27M SERIES B FINANCING |
|
| 4/28/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
OREXIGEN COMPLETES ENROLLMENT OF SECOND PHASE III CONTRAVE TRIAL |
|
| 4/22/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
TARGETRX COMPLETES $9.6MM FINANCING ROUND |
|
| 4/7/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
ORQIS MEDICAL PRESENTS MOMENTUM TRIAL RESULTS AT ACC |
|
| 4/1/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
DIOBEX ANNOUNCES PRESENTATION OF SCIENTIFIC POSTER AT ANNUAL MEETING OF AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS |
|
| 4/1/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
FDA ACCEPTS ZOGENIX NDA FILING |
|
| 3/19/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
DIOBEX AND CAMURUS SIGN LICENSE AGREEMENT FOR THE DEVELOPMENT OF DIO-901 IN FLUIDCRYSTAL EXTENDED RELEASE TECHNOLOGY |
|
| 3/18/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
ALIMERA SCIENCES CLOSES $30 MILLION SERIES C FINANCING |
|
| 3/18/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
SCIELE PHARMA ACQUIRES TWINJECT FROM VERUS PHARMACEUTICALS |
|
| 3/13/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
PHARMION SHAREHOLDERS APPROVE ACQUISTION BY CELGENE |
|
| 3/6/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
CELGENE TO ACQUIRE PHARMION FOR $2.9B |
|
| 11/19/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
CELGENE TO ACQUIRE PHARMION FOR $2.9B |
|
| 11/19/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
CELGENE TO ACQUIRE PHARMION FOR $2.9B |
|
| 11/19/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
CELGENE TO ACQUIRE PHARMION FOR $2.9B |
|
| 11/19/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
CELGENE TO ACQUIRE PHARMION FOR $2.9B |
|
| 11/19/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
OREXIGEN RELEASES SUMMARY OF POSITIVE PHASE 2B CONTRAVE RESULTS IN OBESITY |
|
| 10/21/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
VERUS DIVESTS PEDIATRIC ASTHMA PROGRAM TO ASTRAZENECA |
|
| 10/8/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
VANDA SUBMITS NDA FOR ILOPERIDONE FOR SCHIZOPHRENIA |
|
| 10/8/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
ESPRIT PHARMA TO BE ACQUIRED BY ALLERGAN FOR $370M |
|
| 9/19/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
CELATOR CLOSES $10M SERIES B FOLLOW-ON |
|
| 8/10/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
MERCK ACQUIRES NOVACARDIA FOR $350M PLUS CASH |
|
| 7/25/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
NOVALAR'S NV-101 NDA APPROVED |
|
| 6/19/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
APNEX MEDICAL, INC. RAISES $16.1 MILLION IN SERIES 'A' FINANCING |
|
| 5/14/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
MARINUS INITIATES PHASE IIB STUDY OF GANAXOLONE FOR ADULT PARTIAL SEIZURES |
|
| 5/10/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
OREXIGEN THERAPEUTICS ANNOUNCES PRICING OF ITS INITIAL PUBLIC OFFERING |
|
| 4/27/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
ALIMERA SCIENCES' MEDIDUR(TM) TRIAL EXCEEDS 500 PATIENT MARK IN PHASE 3 TRIAL ENROLLMENT |
|
| 4/24/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
SYNDAX PHARMACEUTICALS LICENSES SELECTIVE HDAC INHIBITOR |
|
| 4/13/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
GENVAULT CORPORATION RAISES $18M FINANCING |
|
| 4/4/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
SYNDAX PHARMACEUTICALS CLOSES $40M SERIES A FINANCING |
|
| 4/3/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
DIOBEX ANNOUNCES SUCCESSFUL COMPLETION OF PHASE 2A TRIAL OF DIO-902, A NOVEL CORTISOL SYNTHESIS INHIBITOR FOR TYPE 2 DIABETES |
|
| 3/27/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
NOVALAR'S NV-101 PRODUCES POSITIVE PHASE II AND III RESULTS |
|
| 3/23/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
TRAGARA PHARMACEUTICALS ANNOUNCES CORPORATE LAUNCH AND SERIES A FINANCING |
|
| 3/14/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
VENTIRX SECURES $28.9MM SERIES A FINANCING |
|
| 3/7/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
ALTEA THERAPEUTICS REPORTS POSITIVE RESULTS FOR BASAL INSULIN TRANSDERMAL PATCH- DIABETES THERAPY |
|
| 3/2/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
FDA ACCEPTS PHARMION MYELOMA DRUG FOR REVIEW |
|
| 3/2/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
ALTEA THERAPEUTICS REPORTS POSITIVE RESULTS FOR BASAL INSULIN TRANSDERMAL PATCH- DIABETES THERAPY |
|
| 3/2/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
CoDa THERAPEUTICS SECURES $10M IN ADDITIONAL SERIES A FINANCING |
|
| 2/22/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
PHARMION ANNOUNCES FDA ACCEPTANCE OF IND FOR ORAL AZACITIDINE |
|
| 1/31/2007 |
|
|
more
|
| |
| |
|
|
| |
